KMS Medisurgi Statistics
Total Valuation
KMS Medisurgi has a market cap or net worth of INR 417.45 million. The enterprise value is 421.91 million.
| Market Cap | 417.45M |
| Enterprise Value | 421.91M |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Sep 23, 2025 |
Share Statistics
KMS Medisurgi has 3.30 million shares outstanding. The number of shares has increased by 0.49% in one year.
| Current Share Class | 3.30M |
| Shares Outstanding | 3.30M |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 68.19% |
| Owned by Institutions (%) | 3.52% |
| Float | 415,790 |
Valuation Ratios
The trailing PE ratio is 70.82.
| PE Ratio | 70.82 |
| Forward PE | n/a |
| PS Ratio | 3.28 |
| PB Ratio | 5.02 |
| P/TBV Ratio | 5.02 |
| P/FCF Ratio | 147.09 |
| P/OCF Ratio | 19.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.29, with an EV/FCF ratio of 148.66.
| EV / Earnings | 71.21 |
| EV / Sales | 3.31 |
| EV / EBITDA | 34.29 |
| EV / EBIT | 47.15 |
| EV / FCF | 148.66 |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.56 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.71 |
| Debt / FCF | 3.08 |
| Interest Coverage | 6.64 |
Financial Efficiency
Return on equity (ROE) is 7.39% and return on invested capital (ROIC) is 7.61%.
| Return on Equity (ROE) | 7.39% |
| Return on Assets (ROA) | 4.58% |
| Return on Invested Capital (ROIC) | 7.61% |
| Return on Capital Employed (ROCE) | 9.74% |
| Weighted Average Cost of Capital (WACC) | 7.61% |
| Revenue Per Employee | 6.37M |
| Profits Per Employee | 296,250 |
| Employee Count | 20 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 3.34 |
Taxes
In the past 12 months, KMS Medisurgi has paid 2.09 million in taxes.
| Income Tax | 2.09M |
| Effective Tax Rate | 26.11% |
Stock Price Statistics
The stock price has increased by +1.20% in the last 52 weeks. The beta is 0.60, so KMS Medisurgi's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +1.20% |
| 50-Day Moving Average | 68.08 |
| 200-Day Moving Average | 42.36 |
| Relative Strength Index (RSI) | 78.41 |
| Average Volume (20 Days) | 10,400 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KMS Medisurgi had revenue of INR 127.41 million and earned 5.93 million in profits. Earnings per share was 1.79.
| Revenue | 127.41M |
| Gross Profit | 32.00M |
| Operating Income | 8.95M |
| Pretax Income | 8.02M |
| Net Income | 5.93M |
| EBITDA | 12.30M |
| EBIT | 8.95M |
| Earnings Per Share (EPS) | 1.79 |
Balance Sheet
The company has 5.05 million in cash and 8.73 million in debt, with a net cash position of -3.68 million or -1.11 per share.
| Cash & Cash Equivalents | 5.05M |
| Total Debt | 8.73M |
| Net Cash | -3.68M |
| Net Cash Per Share | -1.11 |
| Equity (Book Value) | 83.17M |
| Book Value Per Share | 25.15 |
| Working Capital | 46.24M |
Cash Flow
In the last 12 months, operating cash flow was 21.39 million and capital expenditures -18.56 million, giving a free cash flow of 2.84 million.
| Operating Cash Flow | 21.39M |
| Capital Expenditures | -18.56M |
| Free Cash Flow | 2.84M |
| FCF Per Share | 0.86 |
Margins
Gross margin is 25.12%, with operating and profit margins of 7.02% and 4.65%.
| Gross Margin | 25.12% |
| Operating Margin | 7.02% |
| Pretax Margin | 6.29% |
| Profit Margin | 4.65% |
| EBITDA Margin | 9.66% |
| EBIT Margin | 7.02% |
| FCF Margin | 2.23% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.04%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.49% |
| Shareholder Yield | -0.45% |
| Earnings Yield | 1.42% |
| FCF Yield | 0.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |